Trademark: 79361196
Word
STACANTO
Status
Dead
Status Code
402
Status Date
Monday, September 18, 2023
Serial Number
79361196
Mark Type
4000
Filing Date
Tuesday, November 22, 2022
Published for Opposition
Tuesday, June 20, 2023
Abandoned Date
Monday, September 18, 2023

Trademark Owner History
NOVARTIS AG - Owner At Publication

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Oct 9, 2023
Notification Of Effect Of Cancellation Of Intl Reg E-Mailed
Oct 8, 2023
Death Of International Registration
Jul 20, 2023
Extension Of Time To Oppose Received
Jun 20, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 20, 2023
Published For Opposition
May 31, 2023
Notification Of Notice Of Publication E-Mailed
May 11, 2023
Approved For Pub - Principal Register
May 10, 2023
Assigned To Examiner
Feb 25, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 25, 2023
Teas Change Of Correspondence Received
Feb 25, 2023
Teas Change Of Domestic Representatives Address
Feb 25, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 25, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 25, 2023
Teas Change Of Owner Address Received
Feb 14, 2023
Application Filing Receipt Mailed
Feb 9, 2023
New Application Office Supplied Data Entered
Feb 7, 2023
Limitation From Original Application Entered
Jan 26, 2023
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24